In the experiment above, pigs received six laser shots per eye, with the control group receiving saline treatment and test group receiving Eylea™ treatment. Eylea™, an FDA-approved drug, is an anti-vascular endothelial growth factor (anti-VEGF) that prevents vascular growth. The crisp, high resoution brightfield and fluorescein angiography images, captured by the Micron X, show that Eylea™ clearly mitigates the neovascularization induced by laser burn.
A poster presentation by Emily Gordon, et al., from the National Institute of Allergy and Infectious Diseases revealed the observation of cerebral malaria in the mouse retina as imaged by the Phoenix Research Labs retinal camera the Micron IV.
According to the authors “Microcirculation in the retinal vasculature provides a window to image dynamic changes taking place in the central nervous system during CM disease progression.